Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 641 of 1,261
  1. US 9611322

    Fusions of antibodies to CD38 and attenuated interferon alpha

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  2. US 9611260

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  3. US 9610324

    Apolipoprotein mixtures

    Esperion Therapeutics, Inc. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  4. US 9611244

    Cyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  5. US 9610331

    Methods for hematopoietic precursor mobilization

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  6. US 9611330

    Compositions and methods for cancer and cancer stem cell detection and elimination

    The Regents of the University of California · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  7. US 9610261

    Methods of treating Prader-Willi Syndrome

    OVID THERAPEUTICS INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  8. US 9610352

    Lyophilized viral formulations

    ONCOLYTICS BIOTECH INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  9. US 9610309

    Liquid viral formulations

    ONCOLYTICS BIOTECH INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  10. US 9611230

    1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted
  11. US 9603853

    Formulations of viloxazine

    Supernus Pharmaceuticals, Inc. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  12. US 9605077

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  13. US 9605055

    Anti-CD100 antibodies and methods of using the same

    VACCINEX, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  14. US 9604907

    Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

    The Regents of the University of California · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  15. US 9603820

    Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma

    Northwestern University · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  16. US 9603796

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  17. US 9605013

    Derivatives of hemin with antibacterial and antiviral activity

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  18. US 9603906

    Inhalable liquid formulations of DNase I

    Protalix Ltd. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  19. US 9604944

    Arylpiperazine derivatives and methods of utilizing same

    REVIVA PHARMACEUTICALS, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  20. US 9603922

    Modulation of NKT cell activity with antigen-loaded CD1d molecules

    VACCINEX, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  21. US 9604997

    Peri-carbinols

    Aldeyra Therapeutics, Inc. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  22. US 9606124

    Methods of detecting and treating stem-cell containing solid tumors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  23. US 9605255

    Oligonucleotides for making a change in the sequence of a target RNA molecule present in a living cell

    ProQR Therapeutics II B.V. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  24. US 9605263

    Compositions for modulating C9ORF72 expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.